Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Dr. Kavita Patel talks impact of GLP-1 price negotiations
Dr. Kavita Patel joins 'Fast Money' to talk what is next for GLP-1 drug makers. Senior Personal Finance Correspondent Sharon Epperson shares her personal finance tips for 2024 including the benefits of a Roth IRA
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Biden names GLP-1 drugs Ozempic, Wegovy for price negotiation program
The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs, for the second annual round of drug price negotiations, made possible through the Inflation Reduction Act (IRA).
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
STAT
15h
Online marketing for compounded GLP-1 drugs overstates benefits and underplays risks
A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, ...
2d
on MSN
As Lilly Stock Tumble on GLP-1 Demand Worries, CEO Says All Is Well
Sales results disclosed Tuesday raised concern that investors may have overestimated the demand for Zepbound and Mounjaro.
24/7 Wall St. on MSN
2d
Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...
STAT
1d
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
5d
1 in 8 People in the U.S. Has Taken a GLP-1 Drug and Food Brands Are Taking Notice
One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...
Employee Benefit News
2d
A guide to GLP-1 adoption: How employers can add this benefit in 2025
While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...
Convenience Store News
9d
Circana Talks ‘Profound Impact’ GLP-1 Drugs Have on Spending for Food, Beverages, More
This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...
Healio
3d
GLP-1 receptor agonists tied to similar thyroid cancer risk as DPP-IV inhibitors
Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a ...
2d
Lexaria’s human GLP-1 study 5 receives IRB approval
Lexaria Bioscience (LEXX) it has received the necessary independent ethics board approval required for its contract research organization to ...
Hosted on MSN
1d
GLP-1 Trends by CivicScience: Current Users Report Shifts in Retail Shopping and Alcohol Consumption, Plus More Insights
This is just a glimpse of the GLP-1 trends available to CivicScience clients. Want to see the full picture? Let’s talk.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback